Provided by Tiger Trade Technology Pte. Ltd.

Warrior Met Coal LLC

97.77
-3.8800-3.82%
Post-market: 97.770.00000.00%19:30 EDT
Volume:665.95K
Turnover:65.50M
Market Cap:5.14B
PE:23.50
High:103.45
Open:102.10
Low:96.00
Close:101.65
52wk High:111.42
52wk Low:57.53
Shares:52.57M
Float Shares:51.78M
Volume Ratio:1.72
T/O Rate:1.29%
Dividend:0.32
Dividend Rate:0.33%
EPS(TTM):4.16
EPS(LYR):1.08
ROE:10.04%
ROA:5.17%
PB:2.24
PE(LYR):90.53

Loading ...

Warrior Met Coal (HCC) Receives a Hold from RBC Capital

TIPRANKS
·
Apr 09

Press Release: Warrior Sets Date for First Quarter 2026 Earnings Announcement and Investor Conference Call

Dow Jones
·
Apr 08

Do Analyst Downgrades And Weaker Coal Outlook Change The Bull Case For Warrior Met Coal (HCC)?

Simply Wall St.
·
Apr 04

Press Release: Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Apr 02

Press Release: Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update

Dow Jones
·
Apr 01

Coal Stocks Have (Mostly) Benefited from the Iran War. This One Is Falling Like a Rock. -- Barrons.com

Dow Jones
·
Mar 31

Press Release: Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth

Dow Jones
·
Mar 30

Can-Fite’s Partner Vetbiolix Completes Enrollment in Phase 2 Osteoarthritis Study in Dogs Treated with Piclidenoson; Data Expected in Q3 2026

GlobeNewswire
·
Mar 30

Warrior Met Coal Is Maintained at Buy by UBS

Dow Jones
·
Mar 27

Warrior Met Coal price target raised to $105 from $101 at UBS

TIPRANKS
·
Mar 27

Press Release: Akeso Reports Full-Year 2025 Financial Results

Dow Jones
·
Mar 27

Press Release: CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0

Dow Jones
·
Mar 26

Press Release: Can-Fite Reports 2025 Financial Results and Ongoing Clinical Progress Highlighting Positive Data in Phase 2a Pancreatic cancer and 9 Years Cancer-Free Survival in Liver Cancer Patient

Dow Jones
·
Mar 26

Press Release: Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 23

HCC Wins Rs 1,662 Crore JV Contract for Mumbai Goregaon-Mulund Link Road Phase IV

TIPRANKS
·
Mar 19

Warrior Met Coal Is Maintained at Buy by Citigroup

Dow Jones
·
Mar 18

Adagene’s Muzastotug (ADG126) to be Highlighted in Two Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA

GlobeNewswire
·
Mar 18

Can-Fite Expands Namodenoson anti-Obesity Franchise with Israeli Patent Allowance

GlobeNewswire
·
Mar 17